Amarin Corp. Plc (AMRN)
13.97
-0.10
(-0.71%)
USD |
NASDAQ |
Aug 28, 16:00
14.00
+0.03
(+0.21%)
After-Hours: 20:00
Amarin Cash from Operations (Quarterly) : 6.612M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 6.612M |
| March 31, 2026 | 6.377M |
| December 31, 2025 | 15.32M |
| September 30, 2025 | -12.76M |
| June 30, 2025 | 16.69M |
| March 31, 2025 | -12.51M |
| December 31, 2024 | -13.24M |
| September 30, 2024 | -2.435M |
| June 30, 2024 | -2.761M |
| March 31, 2024 | -12.59M |
| December 31, 2023 | -0.6516M |
| September 30, 2023 | 7.361M |
| June 30, 2023 | 7.269M |
| March 31, 2023 | -7.072M |
| December 31, 2022 | -0.2052M |
| September 30, 2022 | -17.33M |
| June 30, 2022 | -64.16M |
| March 31, 2022 | -98.28M |
| December 31, 2021 | -28.14M |
| September 30, 2021 | -4.604M |
| June 30, 2021 | -15.01M |
| March 31, 2021 | -18.77M |
| December 31, 2020 | -38.56M |
| September 30, 2020 | 10.91M |
| June 30, 2020 | 1.594M |
| Date | Value |
|---|---|
| March 31, 2020 | 4.140M |
| December 31, 2019 | -8.974M |
| September 30, 2019 | 21.82M |
| June 30, 2019 | 16.25M |
| March 31, 2019 | -38.49M |
| December 31, 2018 | -32.12M |
| September 30, 2018 | -28.26M |
| June 30, 2018 | -24.29M |
| March 31, 2018 | -9.871M |
| December 31, 2017 | -2.140M |
| September 30, 2017 | -6.551M |
| June 30, 2017 | -11.19M |
| March 31, 2017 | -13.31M |
| December 31, 2016 | -20.34M |
| September 30, 2016 | -18.70M |
| June 30, 2016 | -8.971M |
| March 31, 2016 | -23.31M |
| December 31, 2015 | -25.05M |
| September 30, 2015 | -23.10M |
| June 30, 2015 | -24.63M |
| March 31, 2015 | -11.84M |
| December 31, 2014 | -12.83M |
| September 30, 2014 | -19.30M |
| June 30, 2014 | -11.44M |
| March 31, 2014 | -28.73M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Neurocrine Biosciences, Inc. | 78.00M |
| Alkermes Plc | 145.18M |
| Cellectis SA | -14.34M |
| Akari Therapeutics Plc | -3.112M |
| Liquidia Corp. | 80.24M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 6.124M |
| Cash from Financing (Quarterly) | -0.2495M |
| Free Cash Flow | 15.55M |
| Free Cash Flow Per Share (Quarterly) | 0.3176 |
| Free Cash Flow to Equity (Quarterly) | 6.942M |
| Free Cash Flow to Firm (Quarterly) | 6.612M |
| Free Cash Flow Yield | 5.34% |